Good news! Congratulations to YOCON Biology for being honored as a “National High-tech Enterprise” again!

Yocon Market


Company Events

YOCON Biology (Beijing) Co., Ltd. has been successfully certified as a “National High-tech Enterprise” again by experts from the Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation.


The national high-tech enterprises program is designed to support the high-tech enterprises with independent intellectual property rights. To become national high-tech enterprises, participants have to pass a series of assessment by accreditation bodies jointly established by the Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation, especially in the core independent intellectual property rights, the ability to transform scientific and technological achievements, the R&D and organizational management, and growth indicators.


The examination procedures have become increasingly stringent in recent years, with special focus on the number of patents for inventions, the percentage of R&D investment in sales, and the sales of patented products. Many companies failed to pass the review this year, but we do. The qualification of a national high-tech enterprise is an honor and a reward for us!


YOCON has been focusing on molecular diagnosis and cell therapy in recent years. On the basis of advanced talents strategy, using strong scientific research ability and advanced biotechnology, the company has achieved good social and economic benefits in the industrial development, and has won many national patents through continuous independent R&D innovation, in order to continuously improve our comprehensive competitiveness, and realize the transformation from Made in China to Designed in China!



The honor affirms YOCON’s biological research capability and its overall technical level, and motivates us to make technological innovation, providing trust guarantee for our customers and raising the motivation of the staff. In addition, it also marks the improvement of our biotechnology R&D capability. The recognition by the technical authority will certainly further stimulate the enthusiasm of our R&D staff for technological innovation to further enhance the comprehensive innovation capability with the focus of independent R&D.YOCON will take it as an opportunity and motivation to achieve great-leap-forward development to a higher goal!